-+ 0.00%
-+ 0.00%
-+ 0.00%

Harmony Acquisitions, Vimy Pharma shareholders approve business combination

PUBT·10/22/2026 21:13:08
Listen to the news
Harmony Acquisitions, Vimy Pharma shareholders approve business combination
  • Vimy Pharmaceuticals shareholders approved its combination with Harmony Acquisitions on October 22, 2026; Harmony shareholders backed the deal on October 19.
  • Vimy completed a $2.48 million second financing tranche, issuing 827,533 subscription receipts at $3 each.
  • Total financing proceeds reached $14.54 million from 4,846,354 subscription receipts, supporting product development, commercialization and working capital.
  • Each Vimy common share will be exchanged for one common share of the combined company.
  • Completion is expected in the coming weeks, with the combined company becoming Vimy Pharmaceuticals Corp., trading on the TSXV under “VIMY.”


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Acquisitions Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610221712NEWSFILECNPR____20261022_320371_1) on October 22, 2026, and is solely responsible for the information contained therein.